Imagine spending thousands of dollars on weight-loss medication-only to discover months later that it doesn't work for your ...

The Medicare GLP-1 Bridge may hold the key to Eli Lilly's market share.

At-home health testing platform Ash is expanding its partnership with weight-loss company Noom to bring Noom's Proactive Health Microdose GLP-1Rx Program to market. Noom's program, launched in August, ...

Ozempic was supposed to be a gut story. Then Allison Shapiro looked at the brain scans. An assistant professor at the University of Colorado Anschutz, she was part of a team studying 13 teens and ...

The enormous popularity of new weight-loss drugs often eclipses the downsides: the burden of weekly injections, rough gastrointestinal side effects, muscle and bone loss. That is shaping a race among ...

The story of GLP-1 drugs keeps getting bigger. First they transformed the treatment of diabetes. Then they upended the science — and culture — of weight loss. Now a growing body of research is raising ...

The issuer is solely responsible for the content of this announcement. "GLP-1, a hormone that occurs naturally in the gut, is released after eating and helps the body regulate blood sugar and satiety.

A weight-loss medication eased Serena Williams’s comeback. Experts can’t agree on whether that counts as doping.